PACKAGE LEAFLET: INFORMATION FOR THE USER
Rozex 7.5 mg/g gel
Metronidazole
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
If you have any further questions, ask your doctor or pharmacist.
Contents of the pack:
5 Storage of Rozex
Rozex gel contains metronidazole, an antibiotic belonging to the imidazole group, for cutaneous use.
This medicine is used for the treatment of rosacea.
Do not use Rozex gel
Warnings and precautions
Consult your doctor or pharmacist before starting treatment with Rozex gel.
Using Rozex gel with other medicines
Tell your doctor or pharmacist if you are using or have recently used or might use any other medicines.
Tell your doctor or pharmacist if you are taking, or have recently taken, or might take any other medicines, especially medicines for blood coagulation, alcohol detoxification, and alcohol.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Treatment with Rozex gel is not recommended if you are pregnant or breastfeeding.
Driving and using machines
The influence of this medicine on the ability to drive and use machines is negligible.
Rozex gel containspropyl parahydroxybenzoate (E-216), methyl parahydroxybenzoate (E-218)andpropylene glycol (E-1520)
It may cause allergic reactions (possibly delayed) because it contains propyl parahydroxybenzoate and methyl parahydroxybenzoate.
This medicine contains 30 mg of propylene glycol per gram.
Propylene glycol may cause skin irritation.
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The recommended dose is:
Apply the gel to the affected areas twice a day, in the morning and at night before bedtime.
You can use non-comedogenic (non-acnegenic) and non-astringent cosmetics after applying Rozex.
Use in children
Do not use in children. There is no experience with the use of this medicine in children.
If you use more Rozex than you should
This medicine is not to be ingested. It is for external use only.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately, or go to a medical center, or call the Toxicology Information Service, phone: 91 5620420, indicating the medicine and the amount ingested. It is recommended to bring the packaging and the leaflet to the healthcare professional.
If you forget to use Rozex
Do not apply a double dose to make up for forgotten doses.
If you stop treatment with Rozex gel
Your doctor will indicate the duration of your treatment with Rozex. Do not stop treatment before, as the desired effect will not be achieved.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
This medicine may occasionally cause unwanted side effects at the application site, such as:
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not store above 25°C.
Do not use this medicine after the expiry date which is stated on the packaging after CAD/EXP. The expiry date is the last day of the month shown.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Rozex gel
Appearance of the product and contents of the pack
Rozex is a colorless, pale yellow or slightly brown gel.
Rozex gel is available in packs containing 30 g.
Marketing authorisation holder and manufacturer
Marketing authorisation holder:
Laboratorios Galderma, S.A.
Serrano Galvache, 56
28033 Madrid
Spain
Manufacturer
Laboratoires Galderma
Alby-sur-Chéran
(France)
Date of last revision of this leaflet:02/2021
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es/
The average price of ROZEX 7.5 mg/g GEL in October, 2025 is around 5.37 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.